CDCA7_HUMAN - dbPTM
CDCA7_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CDCA7_HUMAN
UniProt AC Q9BWT1
Protein Name Cell division cycle-associated protein 7
Gene Name CDCA7
Organism Homo sapiens (Human).
Sequence Length 371
Subcellular Localization Nucleus. Cytoplasm. Predominantly nuclear with some expression also seen in the cytoplasm. Predominantly cytoplasmic when phosphorylated at Thr-163.
Protein Description Participates in MYC-mediated cell transformation and apoptosis; induces anchorage-independent growth and clonogenicity in lymphoblastoid cells. Insufficient to induce tumorigenicity when overexpressed but contributes to MYC-mediated tumorigenesis. May play a role as transcriptional regulator..
Protein Sequence MDARRVPQKDLRVKKNLKKFRYVKLISMETSSSSDDSCDSFASDNFANTRLQSVREGCRTRSQCRHSGPLRVAMKFPARSTRGATNKKAESRQPSENSVTDSNSDSEDESGMNFLEKRALNIKQNKAMLAKLMSELESFPGSFRGRHPLPGSDSQSRRPRRRTFPGVASRRNPERRARPLTRSRSRILGSLDALPMEEEEEEDKYMLVRKRKTVDGYMNEDDLPRSRRSRSSVTLPHIIRPVEEITEEELENVCSNSREKIYNRSLGSTCHQCRQKTIDTKTNCRNPDCWGVRGQFCGPCLRNRYGEEVRDALLDPNWHCPPCRGICNCSFCRQRDGRCATGVLVYLAKYHGFGNVHAYLKSLKQEFEMQA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
9UbiquitinationDARRVPQKDLRVKKN
CCCCCCHHHHHHHHH
53.30-
9AcetylationDARRVPQKDLRVKKN
CCCCCCHHHHHHHHH
53.3023749302
9 (in isoform 2)Ubiquitination-53.30-
9UbiquitinationDARRVPQKDLRVKKN
CCCCCCHHHHHHHHH
53.30-
9AcetylationDARRVPQKDLRVKKN
CCCCCCHHHHHHHHH
53.30-
27 (in isoform 2)Phosphorylation-22.4724144214
30 (in isoform 2)Phosphorylation-25.8524144214
31PhosphorylationKLISMETSSSSDDSC
EEEEEECCCCCCCCC
18.2128634120
31 (in isoform 2)Phosphorylation-18.2124144214
32 (in isoform 2)Phosphorylation-41.0824144214
33UbiquitinationISMETSSSSDDSCDS
EEEECCCCCCCCCHH
37.24-
33 (in isoform 2)Phosphorylation-37.2424144214
34 (in isoform 2)Phosphorylation-47.5924144214
37 (in isoform 2)Phosphorylation-25.4724144214
43 (in isoform 2)Phosphorylation-30.9524144214
67PhosphorylationTRSQCRHSGPLRVAM
CHHHCCCCCCEEEEE
23.8224719451
75UbiquitinationGPLRVAMKFPARSTR
CCEEEEEECCCCCCC
38.16-
75SumoylationGPLRVAMKFPARSTR
CCEEEEEECCCCCCC
38.16-
75SumoylationGPLRVAMKFPARSTR
CCEEEEEECCCCCCC
38.16-
75AcetylationGPLRVAMKFPARSTR
CCEEEEEECCCCCCC
38.1625953088
80PhosphorylationAMKFPARSTRGATNK
EEECCCCCCCCCCCC
25.27-
81PhosphorylationMKFPARSTRGATNKK
EECCCCCCCCCCCCC
27.80-
81UbiquitinationMKFPARSTRGATNKK
EECCCCCCCCCCCCC
27.80-
84UbiquitinationPARSTRGATNKKAES
CCCCCCCCCCCCCCC
12.52-
89UbiquitinationRGATNKKAESRQPSE
CCCCCCCCCCCCCCC
22.93-
91PhosphorylationATNKKAESRQPSENS
CCCCCCCCCCCCCCC
40.8721406692
95PhosphorylationKAESRQPSENSVTDS
CCCCCCCCCCCCCCC
40.8628450419
98PhosphorylationSRQPSENSVTDSNSD
CCCCCCCCCCCCCCC
23.4928450419
100PhosphorylationQPSENSVTDSNSDSE
CCCCCCCCCCCCCCC
33.2728450419
102PhosphorylationSENSVTDSNSDSEDE
CCCCCCCCCCCCCCH
28.9428450419
104PhosphorylationNSVTDSNSDSEDESG
CCCCCCCCCCCCHHH
46.6028450419
106PhosphorylationVTDSNSDSEDESGMN
CCCCCCCCCCHHHHH
46.9328450419
110PhosphorylationNSDSEDESGMNFLEK
CCCCCCHHHHHHHHH
56.5228450419
117AcetylationSGMNFLEKRALNIKQ
HHHHHHHHHHHCHHH
45.1526051181
123UbiquitinationEKRALNIKQNKAMLA
HHHHHCHHHHHHHHH
46.9022505724
123AcetylationEKRALNIKQNKAMLA
HHHHHCHHHHHHHHH
46.9025953088
126UbiquitinationALNIKQNKAMLAKLM
HHCHHHHHHHHHHHH
32.4529967540
131UbiquitinationQNKAMLAKLMSELES
HHHHHHHHHHHHHHC
40.54-
131SumoylationQNKAMLAKLMSELES
HHHHHHHHHHHHHHC
40.54-
131SumoylationQNKAMLAKLMSELES
HHHHHHHHHHHHHHC
40.54-
138PhosphorylationKLMSELESFPGSFRG
HHHHHHHCCCCCCCC
49.7426074081
142PhosphorylationELESFPGSFRGRHPL
HHHCCCCCCCCCCCC
16.4126074081
146 (in isoform 2)Phosphorylation-24.8024719451
152PhosphorylationGRHPLPGSDSQSRRP
CCCCCCCCCCCCCCC
31.9528555341
154PhosphorylationHPLPGSDSQSRRPRR
CCCCCCCCCCCCCCC
31.5828555341
154 (in isoform 2)Ubiquitination-31.58-
162UbiquitinationQSRRPRRRTFPGVAS
CCCCCCCCCCCCHHH
41.83-
163PhosphorylationSRRPRRRTFPGVASR
CCCCCCCCCCCHHHC
32.1630576142
168UbiquitinationRRTFPGVASRRNPER
CCCCCCHHHCCCHHH
11.84-
170UbiquitinationTFPGVASRRNPERRA
CCCCHHHCCCHHHHC
32.43-
174 (in isoform 2)Phosphorylation-59.3521406692
175UbiquitinationASRRNPERRARPLTR
HHCCCHHHHCCCCCH
38.5222505724
177 (in isoform 2)Phosphorylation-24.5421406692
179 (in isoform 2)Phosphorylation-36.7821406692
181 (in isoform 2)Phosphorylation-29.3121406692
183 (in isoform 2)Phosphorylation-29.4021406692
185 (in isoform 2)Phosphorylation-25.5621406692
190PhosphorylationSRSRILGSLDALPME
HHHHHHHCCCCCCCC
21.4528674151
202 (in isoform 2)Ubiquitination-64.18-
202UbiquitinationPMEEEEEEDKYMLVR
CCCCHHHHHCEEEEE
64.1822505724
204SumoylationEEEEEEDKYMLVRKR
CCHHHHHCEEEEECC
35.5228112733
204UbiquitinationEEEEEEDKYMLVRKR
CCHHHHHCEEEEECC
35.52-
205UbiquitinationEEEEEDKYMLVRKRK
CHHHHHCEEEEECCC
14.1729967540
205 (in isoform 2)Ubiquitination-14.17-
205PhosphorylationEEEEEDKYMLVRKRK
CHHHHHCEEEEECCC
14.1728796482
210UbiquitinationDKYMLVRKRKTVDGY
HCEEEEECCCCCCCC
51.2522505724
210 (in isoform 2)Ubiquitination-51.25-
212UbiquitinationYMLVRKRKTVDGYMN
EEEEECCCCCCCCCC
56.8022505724
213PhosphorylationMLVRKRKTVDGYMNE
EEEECCCCCCCCCCH
28.0628555341
229PhosphorylationDLPRSRRSRSSVTLP
HCCCCHHCCCCCCHH
35.0925627689
231PhosphorylationPRSRRSRSSVTLPHI
CCCHHCCCCCCHHHE
30.3325627689
242PhosphorylationLPHIIRPVEEITEEE
HHHEECCHHHCCHHH
8.0732645325
262UbiquitinationSNSREKIYNRSLGST
CCCHHHHHHCHHCHH
18.6522505724
264UbiquitinationSREKIYNRSLGSTCH
CHHHHHHCHHCHHHH
19.1122505724
269 (in isoform 2)Phosphorylation-16.5324719451
276UbiquitinationTCHQCRQKTIDTKTN
HHHHHHHHCCCCCCC
28.2629967540
280 (in isoform 3)Phosphorylation-35.6030631047
283 (in isoform 2)Ubiquitination-25.06-
284 (in isoform 2)Phosphorylation-5.5727642862
289UbiquitinationTNCRNPDCWGVRGQF
CCCCCCCCCCCCCCC
3.4322505724
289 (in isoform 2)Ubiquitination-3.43-
291UbiquitinationCRNPDCWGVRGQFCG
CCCCCCCCCCCCCCH
12.9422505724
291 (in isoform 2)Ubiquitination-12.94-
307UbiquitinationCLRNRYGEEVRDALL
HHHHCCCHHHHHHHH
44.37-
319UbiquitinationALLDPNWHCPPCRGI
HHHCCCCCCCCCCCE
22.35-
322UbiquitinationDPNWHCPPCRGICNC
CCCCCCCCCCCEECC
26.32-
349UbiquitinationGVLVYLAKYHGFGNV
HHHHHHHHHCCCCCH
34.87-
350PhosphorylationVLVYLAKYHGFGNVH
HHHHHHHHCCCCCHH
11.1024114839
355UbiquitinationAKYHGFGNVHAYLKS
HHHCCCCCHHHHHHH
21.8229967540
359PhosphorylationGFGNVHAYLKSLKQE
CCCCHHHHHHHHHHH
10.3724114839
361UbiquitinationGNVHAYLKSLKQEFE
CCHHHHHHHHHHHHH
40.8629967540
364SumoylationHAYLKSLKQEFEMQA
HHHHHHHHHHHHHCC
55.67-
364UbiquitinationHAYLKSLKQEFEMQA
HHHHHHHHHHHHHCC
55.6722505724
364SumoylationHAYLKSLKQEFEMQA
HHHHHHHHHHHHHCC
55.67-
416Ubiquitination----------------------------------------------------
----------------------------------------------------
22505724
428 (in isoform 2)Ubiquitination--
440Ubiquitination----------------------------------------------------------------------------
----------------------------------------------------------------------------
29967540
440 (in isoform 2)Ubiquitination--
443 (in isoform 2)Ubiquitination--
443Ubiquitination-------------------------------------------------------------------------------
-------------------------------------------------------------------------------
22505724

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
163TPhosphorylationKinaseAKT1P31749
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
163TPhosphorylation

23186163
163TPhosphorylation

23186163

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CDCA7_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049
1433T_HUMANYWHAQphysical
26186194
1433S_HUMANSFNphysical
26186194
1433Z_HUMANYWHAZphysical
26186194
1433F_HUMANYWHAHphysical
26186194
1433Z_HUMANYWHAZphysical
28514442
1433G_HUMANYWHAGphysical
28514442
1433F_HUMANYWHAHphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CDCA7_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP